Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo
Roberto Bei(University of Rome Tor Vergata), Laura Masuelli(Sapienza University of Rome)
Cited by 8
Related Papers
<i>In vitro</i>and<i>in vivo</i>inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors
|Oncotarget|2016|111
Multifaceted Role of the Placental Growth Factor (PlGF) in the Antitumor Immune Response and Cancer Progression
|International Journal of Molecular Sciences|2019|84
In Vitro and In Vivo Anti-tumoral Effects of the Flavonoid Apigenin in Malignant Mesothelioma
|Frontiers in Pharmacology|2017|77
Apigenin induces apoptosis and impairs head and neck carcinomas EGFR/ErbB2 signaling
|Frontiers in bioscience|2010|71